Skip to main content
. 2020 Jan 14;8(3):e1127. doi: 10.1002/mgg3.1127

Table 1.

Clinical data of symptomatic patients of the pedigree with CMTX

Samples III24 III26 III27 IV27 IV34 V2 IV17
Sex M M M M M M F
Age at first exam, years 54 42 49 35 25 25 57
Age at onset, years Puberty Puberty Puberty 10+ 14 After 20 Approximately 20
Initial symptoms LLW LLW LLW LLW LLW MLLA PC
Muscle weakness§
UL ++ + + + +
LL ++ ++ ++ + + ++
Muscle atrophy (UL/LL) +++ +++ ++ ++ ++ + ++
Tendon reflexes (UL/LL)|| L/L L/L D/L L/L D/L N/N N/L
Pes cavuslll + + + + +
Gait disturbancelll + + + + + +
Hand tremorlll +
Sensory losslll + +
Electromyographyllll NA NA NA NA A A NA

M: Male, F: Female.

LLW: lower limb weakness, MLLA: mild lower limb atrophy, PC: pes cavus.

§

MRC strength grade for upper limbs (bilateral intrinsic hand muscles)/lower limbs (bilateral foot dorsiflexors), UL: upper limbs, LL: lower limbs, ‐: normal, +: distal weakness ≥ 3/5, + +: distal weakness < 3/5.

+: mild atrophy in distal limbs, + +: moderate atrophy in distal limbs, + + +: severe distal limbs or proximal muscle atrophy.

||

L: loss, D: decreased, N: normal.

lll

‐: absence, +: presence Electromyography.

llll

A: abnormal, N: normal, NA: No available data.